Calliditas Therapeutics AB (publ)

CALT · NASDAQ
Analyze with AI
$40.00−$0.0399 (−0.1%)
At close:Sep 20, 2024, 8:00 PM UTC
$40.00+$0.00 (+0%)
After hours:Sep 20, 2024, 7:53 PM UTC
P/E TTM-23.95
P/B TTM33.34
P/S TTM9.31
Dividend Yield0%
EPS-$1.76
Beta1.457
Valuation
PEG Ratio-2.82
FCF Yield-3.98%
EV / EBITDA-30.57
Quality
ROIC-25.82%
Gross Margin93.62%
Cash Conv. Ratio0.57
Growth
Revenue 3Y CAGR73.94%
FCF Growth-42.56%
Safety
Net Debt / EBITDA-0.01
Interest Coverage-3.36
Efficiency
Inventory Turnover3.77
Cash Conv. Cycle-322.67

Calliditas Therapeutics AB (publ) (CALT) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Calliditas Therapeutics AB (publ) (CALT) stock price today?

As of Sep 20, 2024, 8:00 PM UTC, Calliditas Therapeutics AB (publ) (CALT) stock is trading at $40.00. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CALT stock quotes for informed trading decisions.

What is Calliditas Therapeutics AB (publ)'s market capitalization?

Calliditas Therapeutics AB (publ) (CALT) has a market capitalization of approximately $2.1B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Calliditas Therapeutics AB (publ)'s size relative to other companies in the USD market. The market cap figure updates automatically as the CALT stock price changes.

What is the 52-week range for Calliditas Therapeutics AB (publ) stock?

Calliditas Therapeutics AB (publ) (CALT) stock has traded in a 52-week range of $15.25 — $43.00. The 52-week range shows the highest and lowest prices at which CALT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Calliditas Therapeutics AB (publ) stock price to this range provides context for recent price action.

How much trading volume does Calliditas Therapeutics AB (publ) stock have?

Calliditas Therapeutics AB (publ) (CALT) stock recently traded approximately 9.8K shares. Trading volume indicates market liquidity and investor interest in CALT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Calliditas Therapeutics AB (publ) stock.

Does Calliditas Therapeutics AB (publ) pay dividends to shareholders?

Yes, Calliditas Therapeutics AB (publ) (CALT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Calliditas Therapeutics AB (publ) stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Calliditas Therapeutics AB (publ)'s intraday price range?

Today, Calliditas Therapeutics AB (publ) (CALT) stock has traded in a range of $40.00 — $43.00. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CALT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Calliditas Therapeutics AB (publ) stock data?

AlphaPilot sources real-time CALT stock quotes, fundamental financial data, and historical price charts for Calliditas Therapeutics AB (publ) from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Calliditas Therapeutics AB (publ) stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CALT stock performance.